Leukemia, Myelodysplasia, Transplantation
News
Risk-directed therapy improves survival in ALL
Credit: St Jude Biomedical Communications Risk-directed therapy can level the playing field for patients with BCR-ABL1-like acute lymphoblastic...
News
Combo can improve survival in certain AML patients
However, the combination did confer a survival benefit when transplant patients were excluded from the analysis and in patients age 60 and older...
News
Animal studies help explain chemo brain
californica releasing ink after being disturbed Results of preclinical research appear to explain how the anticancer agent doxorubicin can cause...
News
NICE rejects obinutuzumab for CLL
Credit: Linda Bartlett In a new draft guidance, the UK’s National Institute for Health and Care Excellence (NICE) has said it cannot recommend...
News
Product appears safe, effective in rel/ref ALL
Credit: Bill Branson Eryaspase, a product consisting of L-asparaginase encapsulated in red blood cells, may be safer and more effective than...
Conference Coverage
Targeting drug resistance earlier
Credit: PNAS PHILADELPHIA—A combination treatment strategy that takes tumor evolution into account could help us avoid drug resistance in...
News
Hypercalcemia may be indicator for hematologic cancers
Credit: Graham Colm Hypercalcemia could be an early indication of cancer, according to a study published in the British Journal of Cancer. The...
Conference Coverage
Drug can prevent chemo-induced nausea, vomiting
Credit: Rhoda Baer MADRID—A small molecule called rolapitant can prevent nausea and vomiting in patients receiving cisplatin-based chemotherapy,...
Conference Coverage
Preventing cancer-related infection
Credit: CDC/Kimberly Smith and Christine Ford NEW YORK—Hand washing is still the single most effective method to prevent the transmission of...
Conference Coverage
Speaker offers alternatives for sustainable TKI use in CML
NEW YORK—If any oncology drugs warrant a high price, BCR-ABL tyrosine kinase inhibitors (TKIs) could make a strong case, according to a speaker at...
Conference Coverage
Method can detect drivers of AML
PHILADELPHIA—Super-enhancer profiling can unearth biomarkers and therapeutic targets for acute myeloid leukemia (AML), according to research...